The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

NCT05560035 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Metastatic Cancer

Interventions

DRUG: Lidocaine
OTHER: Normal saline (NS)

Sponsor

General Hospital of Ningxia Medical University